Journal of Molecular Oncology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Journal of Molecular Oncology Research (2022) Volume 6, Issue 5

Cervical cancer treatments: Current challenges and future points of view

Cervical cancer is the fourth most common female cancer around the world and comes about in over 300 000 passings universally. The causative operator of cervical cancer is diligent contamination with high-risk subtypes of the human papillomavirus and the E5, E6 and E7 viral oncoproteins participate with have variables to initiate and keep up the dangerous phenotype. Cervical cancer could be a generally preventable malady and early-stage location is related with altogether moved forward survival rates. Without a doubt, in high-income nations with established vaccination and screening programs it could be an uncommon infection. Be that as it may, the infection could be an executioner for ladies in moo- and middle-income nations who, due to constrained assets, regularly show with progressed and untreatable infection. Treatment alternatives incorporate surgical intercessions, chemotherapy and/or radiotherapy either alone or in combination. This audit depicts the start and movement of cervical cancer and talks about in profundity the focal points and challenges confronted by current cervical cancer treatments, taken after by a talk of promising and solid unused treatments to treat cervical cancer counting immunotherapies, focused on treatments, combination treatments, and hereditary treatment approaches.

Author(s): Sharon Prince

Abstract Full Text PDF

Get the App